DGX - Quest Diagnostics Incorporated

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 15.55B
Enterprise value 19.99B
Trailing P/E 20.32
Forward P/E 15.97
PEG Ratio (5 yr expected) 3.30
Price/sales (ttm)1.68
Price/book (mrq)2.57
Enterprise value/revenue 2.02
Enterprise value/EBITDA 10.99

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-3.42%
S&P500 52-week change 32.54%
52-week high 3158.34
52-week low 3120.40
50-day moving average 3137.99
200-day moving average 3139.67

Share statistics

Avg vol (3-month) 31.11M
Avg vol (10-day) 3904.27k
Shares outstanding 5112.01M
Implied shares outstanding 6N/A
Float 8111.01M
% held by insiders 10.83%
% held by institutions 192.97%
Shares short (14 May 2023) 44.08M
Short ratio (14 May 2023) 43.78
Short % of float (14 May 2023) 44.78%
Short % of shares outstanding (14 May 2023) 43.64%
Shares short (prior month 13 Apr 2023) 44.12M

Dividends & splits

Forward annual dividend rate 42.84
Forward annual dividend yield 42.12%
Trailing annual dividend rate 32.69
Trailing annual dividend yield 32.01%
5-year average dividend yield 41.90
Payout ratio 439.39%
Dividend date 324 Jul 2023
Ex-dividend date 409 Jul 2023
Last split factor 22:1
Last split date 320 Jun 2005

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 8.26%
Operating margin (ttm)14.07%

Management effectiveness

Return on assets (ttm)6.44%
Return on equity (ttm)13.57%

Income statement

Revenue (ttm)9.6B
Revenue per share (ttm)84.05
Quarterly revenue growth (yoy)-10.70%
Gross profit (ttm)3.47B
Net income avi to common (ttm)789M
Diluted EPS (ttm)6.83
Quarterly earnings growth (yoy)-43.10%

Balance sheet

Total cash (mrq)175M
Total cash per share (mrq)1.56
Total debt (mrq)4.62B
Total debt/equity (mrq)74.97
Current ratio (mrq)1.34
Book value per share (mrq)54.02

Cash flow statement

Operating cash flow (ttm)1.33B
Levered free cash flow (ttm)554.88M